Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph E Tomaszewski

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Preclinical modeling of a phase 0 clinical trial: qualification of a pharmacodynamic assay of poly (ADP-ribose) polymerase in tumor biopsies of mouse xenograftsRobert J Kinders, Melinda Hollingshead, Sonny Khin, et al.
Rapid Communications in Mass Spectrometry : RCM|September 5, 2003
Quantitative analysis of betulinic acid in mouse, rat and dog plasma using electrospray liquid chromatography/mass spectrometryXun Cheng, Young Geun Shin, Barry S Levine, et al.
Future Medicinal Chemistry|March 24, 2011
Institutional profile: Developing and evaluating new drugs for cancer treatment: perspectives from the US National Cancer InstituteEdward L Trimble, Jeffrey S Abrams, Sherry S Ansher, et al.
BMC Medicine|March 10, 2012
Advances in using PARP inhibitors to treat cancerShivaani Kummar, Alice Chen, Ralph E Parchment, et al.
Journal of Hematology & Oncology|February 6, 2015
Notch1 phenotype and clinical stage progression in non-small cell lung cancerDat Nguyen, Larry Rubinstein, Naoko Takebe, et al.
Plos One|October 27, 2011
Modeling pharmacodynamic response to the poly(ADP-Ribose) polymerase inhibitor ABT-888 in human peripheral blood mononuclear cellsJiuping Ji, Robert J Kinders, Yiping Zhang, et al.
Molecular Oncology|June 5, 2016
Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axisDimiter B Avtanski, Arumugam Nagalingam, Joseph E Tomaszewski, et al.
Reproductive Toxicology (Elmsford, N.Y.)|October 27, 2004
The effects of tetrathiomolybdate (TTM, NSC-714598) and copper supplementation on fertility and early embryonic development in ratsAlexander V Lyubimov, Jeffry A Smith, Serge D Rousselle, et al.
Statistics in Medicine|April 27, 2010
The statistics of phase 0 trialsLarry V Rubinstein, Seth M Steinberg, Shivaani Kummar, et al.
Molecular Cancer|July 15, 2009
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cellsShizuko Sei, Jodie K Mussio, Quan-en Yang, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Preclinical modeling of a phase 0 clinical trial: qualification of a pharmacodynamic assay of poly (ADP-ribose) polymerase in tumor biopsies of mouse xenograftsRobert J Kinders, Melinda Hollingshead, Sonny Khin, et al.
Rapid Communications in Mass Spectrometry : RCM|September 5, 2003
Quantitative analysis of betulinic acid in mouse, rat and dog plasma using electrospray liquid chromatography/mass spectrometryXun Cheng, Young Geun Shin, Barry S Levine, et al.
Future Medicinal Chemistry|March 24, 2011
Institutional profile: Developing and evaluating new drugs for cancer treatment: perspectives from the US National Cancer InstituteEdward L Trimble, Jeffrey S Abrams, Sherry S Ansher, et al.
BMC Medicine|March 10, 2012
Advances in using PARP inhibitors to treat cancerShivaani Kummar, Alice Chen, Ralph E Parchment, et al.
Journal of Hematology & Oncology|February 6, 2015
Notch1 phenotype and clinical stage progression in non-small cell lung cancerDat Nguyen, Larry Rubinstein, Naoko Takebe, et al.
Plos One|October 27, 2011
Modeling pharmacodynamic response to the poly(ADP-Ribose) polymerase inhibitor ABT-888 in human peripheral blood mononuclear cellsJiuping Ji, Robert J Kinders, Yiping Zhang, et al.
Molecular Oncology|June 5, 2016
Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axisDimiter B Avtanski, Arumugam Nagalingam, Joseph E Tomaszewski, et al.
Reproductive Toxicology (Elmsford, N.Y.)|October 27, 2004
The effects of tetrathiomolybdate (TTM, NSC-714598) and copper supplementation on fertility and early embryonic development in ratsAlexander V Lyubimov, Jeffry A Smith, Serge D Rousselle, et al.
Statistics in Medicine|April 27, 2010
The statistics of phase 0 trialsLarry V Rubinstein, Seth M Steinberg, Shivaani Kummar, et al.
Molecular Cancer|July 15, 2009
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cellsShizuko Sei, Jodie K Mussio, Quan-en Yang, et al.
Pageof 5